BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 33412003)

  • 1. m
    Huff S; Tiwari SK; Gonzalez GM; Wang Y; Rana TM
    ACS Chem Biol; 2021 Feb; 16(2):324-333. PubMed ID: 33412003
    [No Abstract]   [Full Text] [Related]  

  • 2. m
    Cui Q; Shi H; Ye P; Li L; Qu Q; Sun G; Sun G; Lu Z; Huang Y; Yang CG; Riggs AD; He C; Shi Y
    Cell Rep; 2017 Mar; 18(11):2622-2634. PubMed ID: 28297667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational Design and Optimization of m
    Huff S; Kummetha IR; Zhang L; Wang L; Bray W; Yin J; Kelley V; Wang Y; Rana TM
    J Med Chem; 2022 Aug; 65(16):10920-10937. PubMed ID: 35939803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical Inhibitors Targeting the Oncogenic m
    Huang Y; Xia W; Dong Z; Yang CG
    Acc Chem Res; 2023 Nov; 56(21):3010-3022. PubMed ID: 37889223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small-Molecule Inhibitors of the RNA M6A Demethylases FTO Potently Support the Survival of Dopamine Neurons.
    Selberg S; Yu LY; Bondarenko O; Kankuri E; Seli N; Kovaleva V; Herodes K; Saarma M; Karelson M
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33926120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural insights into FTO's catalytic mechanism for the demethylation of multiple RNA substrates.
    Zhang X; Wei LH; Wang Y; Xiao Y; Liu J; Zhang W; Yan N; Amu G; Tang X; Zhang L; Jia G
    Proc Natl Acad Sci U S A; 2019 Feb; 116(8):2919-2924. PubMed ID: 30718435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Specific
    Zhang Y; Li QN; Zhou K; Xu Q; Zhang CY
    Anal Chem; 2020 Oct; 92(20):13936-13944. PubMed ID: 32972135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5.
    Huang Y; Yan J; Li Q; Li J; Gong S; Zhou H; Gan J; Jiang H; Jia GF; Luo C; Yang CG
    Nucleic Acids Res; 2015 Jan; 43(1):373-84. PubMed ID: 25452335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small-Molecule Targeting of Oncogenic FTO Demethylase in Acute Myeloid Leukemia.
    Huang Y; Su R; Sheng Y; Dong L; Dong Z; Xu H; Ni T; Zhang ZS; Zhang T; Li C; Han L; Zhu Z; Lian F; Wei J; Deng Q; Wang Y; Wunderlich M; Gao Z; Pan G; Zhong D; Zhou H; Zhang N; Gan J; Jiang H; Mulloy JC; Qian Z; Chen J; Yang CG
    Cancer Cell; 2019 Apr; 35(4):677-691.e10. PubMed ID: 30991027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. m
    Liu J; Ren D; Du Z; Wang H; Zhang H; Jin Y
    Biochem Biophys Res Commun; 2018 Aug; 502(4):456-464. PubMed ID: 29842885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural characteristics of small-molecule inhibitors targeting
    Gao S; Li X; Zhang M; Zhang N; Wang R; Chang J
    Future Med Chem; 2021 Sep; 13(17):1475-1489. PubMed ID: 34240624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion.
    Su R; Dong L; Li Y; Gao M; Han L; Wunderlich M; Deng X; Li H; Huang Y; Gao L; Li C; Zhao Z; Robinson S; Tan B; Qing Y; Qin X; Prince E; Xie J; Qin H; Li W; Shen C; Sun J; Kulkarni P; Weng H; Huang H; Chen Z; Zhang B; Wu X; Olsen MJ; Müschen M; Marcucci G; Salgia R; Li L; Fathi AT; Li Z; Mulloy JC; Wei M; Horne D; Chen J
    Cancer Cell; 2020 Jul; 38(1):79-96.e11. PubMed ID: 32531268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential m
    Wei J; Liu F; Lu Z; Fei Q; Ai Y; He PC; Shi H; Cui X; Su R; Klungland A; Jia G; Chen J; He C
    Mol Cell; 2018 Sep; 71(6):973-985.e5. PubMed ID: 30197295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FTO, m
    Mauer J; Jaffrey SR
    FEBS Lett; 2018 Jun; 592(12):2012-2022. PubMed ID: 29754392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FTO-Dependent
    Huang H; Wang Y; Kandpal M; Zhao G; Cardenas H; Ji Y; Chaparala A; Tanner EJ; Chen J; Davuluri RV; Matei D
    Cancer Res; 2020 Aug; 80(16):3200-3214. PubMed ID: 32606006
    [No Abstract]   [Full Text] [Related]  

  • 16. Discovery of two novel ALKBH5 selective inhibitors that exhibit uncompetitive or competitive type and suppress the growth activity of glioblastoma multiforme.
    Takahashi H; Hase H; Yoshida T; Tashiro J; Hirade Y; Kitae K; Tsujikawa K
    Chem Biol Drug Des; 2022 Jul; 100(1):1-12. PubMed ID: 35384315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Potent and Selective Inhibitors of Fat Mass Obesity-Associated Protein Using a Fragment-Merging Approach.
    Prakash M; Itoh Y; Fujiwara Y; Takahashi Y; Takada Y; Mellini P; Elboray EE; Terao M; Yamashita Y; Yamamoto C; Yamaguchi T; Kotoku M; Kitao Y; Singh R; Roy R; Obika S; Oba M; Wang DO; Suzuki T
    J Med Chem; 2021 Nov; 64(21):15810-15824. PubMed ID: 34727689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct RNA
    Toh JDW; Crossley SWM; Bruemmer KJ; Ge EJ; He D; Iovan DA; Chang CJ
    Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25284-25292. PubMed ID: 32989163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel positioning from obesity to cancer: FTO, an m
    Chen J; Du B
    J Cancer Res Clin Oncol; 2019 Jan; 145(1):19-29. PubMed ID: 30465076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meclofenamic acid promotes cisplatin-induced acute kidney injury by inhibiting fat mass and obesity-associated protein-mediated m
    Zhou P; Wu M; Ye C; Xu Q; Wang L
    J Biol Chem; 2019 Nov; 294(45):16908-16917. PubMed ID: 31578283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.